FDA Investigator Patricia A Morrow
Patricia A Morrow has conducted inspections on 86 sites in 1 countries as of 25 Mar 2014. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
86
Last Inspection Date:
25 Mar 2014
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Patricia A Morrow:
Amanda B Athey,
Amanda B Vega,
Amy A Johnson,
Amy C Amaro,
Ana P Barido,
Andrea L Williams Jones,
Andrew J Howard,
Andrew O Ejiofor,
Ann Marie Montemurro,
Anthony W Lee,
Arduino Frankovic,
Armando P Zamora,
Ashley M Whitehurst,
Austin B Appler,
Barbara A Burke,
Barbara A Gullick,
Barbara J Holladay,
Brandon L Mariner,
Brian M Palermo,
Brooke K Higgins,
Brooke K Seeman,
Bruce C Kovak,
Burnell M Henry,
Camilla S Smith,
Carole L Jones,
Carrie L Doupnik,
Cassandra K Johnson,
Charles D Boison,
Charles E Idjagboro,
Charles M Kerns, BLT DO,
Cherlita A Honeycutt,
Christian D Lynch (CDL),
Christine W Twohy,
Clarice J Ahn,
Colleen F Hoyt,
Cynthia A Harris, MD, RN,
Danielle R Rainey,
David P Rice, Jr,
Diane T Bargo,
Diane T O'brien,
Dung N Tran,
Edette J Newby,
Edmund F Mrak, Jr,
Edward P Potter,
Edwin Melendez,
Eileen A Liu,
Elvis D Morton,
Emest F Bizjak,
Erika M Wilkerson,
Erin L Mcfiren,
Frederick F Razzaghi,
Gabriel Feng,
Gail L Katz,
Gale L Glinecki,
Gene D Arcy,
Gerald Mierle,
Heath R Harley,
Helen B Ricalde,
Holly S Simms,
Hyesuk Kong,
J David Doleski,
Jacqueline Johnson,
Jacquelyn D Hokamp,
James L Kenney, DSc,
James M Simpson,
James T Mccoy,
James W Leonette,
Jamie D Swann,
Jeanne D Shaffer,
Jeffrey A Reed,
Jessica D Nanini,
Jessica D Weber,
John Dan,
John M Gusto,
John M Mcinnis,
Johnson,
Jonathan W Chapman,
Joseph W Matthews,
Jude C Dikes,
Julie A Silberberg,
Justin A Hefferman,
Justin H Price,
Karen M Cooper,
Kellie L Westerbuhr,
Kelly Dragon,
Kenneth L Smalls,
Krista N Flores,
La Tasham Gunter,
Lakisha M Williams,
Latoya S Oliver Powell,
Laurissa S Flowers,
LCDR Anastasia M Piliafas Brown,
LCDR Cornelius Brown, III,
Linda S Mattingly,
Lori S Lawless,
Lorraine L Chavis,
LT John M Mastalski,
Lynette P Salisbury,
Marc S Neubauer,
Marcellinus D Dordunoo,
Margaret Torres Vazquez,
Marion W Nadeau,
Mary T Carden,
Matthew M Henciak,
Melissa D Kalik,
Melissa J Garcia,
Merideth K Rose,
Michael L Zimmerman,
Michelle E Noonan Smith,
Mildred L Mccray,
Mohamad A Chahine,
Monique Rac Lester,
Myra L Gemmill,
Myra L Reed,
Nancy L Meade,
Nancy L Rose,
Natasha A Dezinna,
Natasha A Harry,
Nebil A Oumer,
Nerizza B Guerin,
Nina D Patel,
Normica G Facey,
Osama M Hamoud,
Paula J Bretz,
Prabhu P Raju,
Priscilla M Pastrana,
Rachael A Wiederock,
Rachel C Harrington,
Rebecca Rodriguez,
Regina Gibson Melton,
Renisha M Shaw,
Richard J Bashay,
Robert Jennings,
Rona A Leblanc, PhD,
Ronald T Nowalk,
Samuel M Aboagye,
Sarah M Shannon,
Sharon K Thoma, PharmD,
Shavon L Square,
Sherry L Secrist, BLT DO,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Sidney B Priesmeyer,
Stacey A Priest,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Steven P Donald,
Susan M Jackson,
Suzanne M Healy,
Suzanne M Muchene,
Tajah L Blackburn,
Tamara N Champion,
Tamika E Allen, RN,
Tania E Vizcaino,
Theresa M Smedley,
Thomas W Nojek,
Troy C Quander,
Valerie G Vallely,
Victoria V Bot,
Vipulchandra N Dholakia,
Walter L Fava,
Wanda Y Fields,
Wanda Y Honeyblue,
Wayne L Jefferson,
William D Murray,
William J Leonard
Patricia A Morrow's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2013 | FDA 483 | Bell-More Labs Inc - Form 483, 2013-07-25 |
July, 2011 | EIR | Osiris Therapeutics Inc - EIR, 2011-07-14 |
November, 2008 | EIR | PAREXEL INTERNATIONAL CORPORATION - EIR, 2008-11-18 |
February, 2012 | FDA 483 Response | Inova Health Care Services - Form 483R, 2012-03-15 |
February, 2012 | FDA 483 | Inova Health Care Services - Form 483, 2012-03-14 |
January, 2010 | EIR | Fisher Bioservices - EIR, 2010-01-06 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more